1 A method for inhibiting 11.beta.HSD1 by administering a compound of formula (I) is described, wherein A, X, Y, R.sup.1, R.sup.12, n, q, and m are as described in the specification. Novel compounds and methods employing them are also described and claimed.

 
Web www.patentalert.com

< Use of creatine analogues and creatine kinase modulators for the prevention and treatment of glucose metabolic disorders

< Tetrahydronaphthyridine derivatives

> Novel human seven transmembrane proteins and polynucleotides encoding the same

> Melanin concentrating hormone receptor antagonists
~ 00221